Jamaica, Brazil, and Cuba, have been excluded from the deal between Pfizer Inc. and the Medicines Patent Pool (MPP) and will have to buy pills directly from Pfizer, likely at higher prices. The two companies announced the signing of a voluntary license agreement for Pfizer’s COVID-19 oral antiviral treatment candidate PF-07321332 this week, and will enable MPP to facilitate additional production and […]